A new global hub for cancer research and treatment is set to be established in London with the aim of accelerating the discovery of new treatments.
The new London Cancer Hub will based in Sutton, south London, and is a partnership between The Institute of Cancer Research, London, The Royal Marsden NHS Foundation Trust and the London Borough of Sutton.
In a statement the partners said that the Hub could potentially create over 13,000 jobs and will deliver at least two extra cancer drugs every five years.
The initiative aims to bring together 10,000 scientists, clinical and support staff, and offer research and development space for biotech, pharma, software companies, and equipment manufacturers. The buildings will closely integrate research and cancer care – providing both laboratories and clinical facilities, in order to drive interactions between scientists and clinicians.
“This is a fantastically exciting project to create the world’s leading cancer research campus here in London,” said Professor Paul Workman, Chief Executive of The Institute of Cancer Research, London. “The ICR and The Royal Marsden are already world leaders in cancer research and treatment, but by working with the London Borough of Sutton and the Greater London Authority, we aim to take our facilities and outputs to a new level. The ambition is to discover more innovative cancer drugs, to run more clinical trials, and to partner with industry to take even more treatments to patients.”